Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Methanol | HCID 887 | — |
| Reactant | 3-azetidinecarboxylic Acid | HCID 93192 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | 3-(4-Cyclohexyl-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-c]isoxazole-7-carbaldehyde | HCID 86669933 | — |
| Solvent | 1,2-Dichloroethane | HCID 11 | — |
| Product | Trifluoroacetic acid | HCID 6422 | 52.3% |
| Product | 1-((3-(4-Cyclohexyl-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)methyl)azetidine-3-carboxylic acid | HCID 67170391 | — |
Reaction Steps
A mixture of 3-(4-cyclohexyl-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-c]isoxazole-7-carbaldehyde (Preparation 118E, 20 mg, 0.047 mmol), 1,2-dichloroethane (0.4 mL), MeOH (0.4 mL), azetidine-3-carboxylic acid (14.26 mg, 0.141 mmol) and acetic acid (0.016 mL, 0.282 mmol) was heated at 50° C. (oil bath temp.) for 1 h under nitrogen. The mixture was cooled to room temperature and sodium triacetoxyborohydride (29.9 mg, 0.141 mmol) was added in one lot. The contents were stirred at room temperature for 3 hr. The mixture was concentrated and dissolved in methanol (1.8 mL) and dichloromethane (0.2 mL). Purification using reverse phase HPLC (Phenomenex Luna AXIA 5 u c18 30×100 mm, 10 min. run, solvent A: 10% MeOH: 90% H2O: 0.1% TFA, solvent B: 90% MeOH, 10% H2O, 0.1% TFA), concentration and lyophilization gave 1-((3-(4-cyclohexyl-3-(trifluoromethyl)phenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)methyl)azetidine-3-carboxylic acid, TFA (16 mg, 0.025 mmol, 52.3% yield) as a white solid. The compound had an HPLC retention time=3.77 min. (condition C); LC/MS M+1=511.2; 1H NMR (400 MHz, MeOD) δ ppm 7.99-8.05 (3H, m), 7.78 (1H, d, J=8.6 Hz), 7.51 (1H, d, J=1.1 Hz), 7.47 (1H, dd, J=7.9, 1.8 Hz), 4.46 (2H, s), 4.33-4.38 (4H, m), 3.63-3.74 (1H, m), 3.09-3.15 (4H, m), 3.00 (1H, t, J=11.7 Hz), 1.77-1.96 (5H, m), 1.54-1.67 (2H, m, J=12.0, 12.0, 11.9, 2.1 Hz), 1.35-1.53 (3H, m).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09216972B2 |
|---|
| Source dataset | uspto-grants-2015_12 |
|---|
| ORD ID | ord-f4a9c925aee94144b0ec42dbcdf246e7 |
|---|
| Source note | uspto-grants-2015_12 |
|---|